
List of corporate sponsors
We thank our corporate sponsors for making the work of fighting kidney disease on all fronts possible. These organizations help ensure that every kidney patient has access to health care and every person at risk for this chronic health condition is empowered to prevent it.

Thank you to our major corporate sponsors
The following sponsors supported the programs and services of the American Kidney Fund with generous contributions of $5,000 or more. You can also view our Corporate Members here.
($500,000+)
AstraZeneca Pharmaceuticals LP
GlaxoSmithKline
($100,000–$499,999)
Akebia Therapeutics, Inc.
Alnylam Pharmaceuticals, Inc.
Amgen USA
Cara Therapeutics
DaVita Healthcare Partners, Inc
FMC Renal Pharmaceuticals
Horizon Therapeutics
Otsuka America Pharmaceutical Inc.
Tricida Inc
Vertex, Inc.
($50,000–$99,999)
Abbott Nutrition
Alexion Pharmaceuticals, Inc.
Ardelyx, Inc.
Rockpointe Corporation
Satellite Healthcare Inc
Truist Foundation - formerly Suntrust
($25,000–$49,999)
Gentian
Quest Diagnostics
Relypsa, Inc.
Right Advisory LLC
Travere
($5,000–$24,999)
American Society of Nephrology
Apellis Pharmaceuticals, Inc.
Aurinia Biotechnology Innovation Organization (BIO)
ColorNet Printing & Graphics
Dime Community Bank
EventEQ
Federal Street Strategies LLC
Flushing Bank
Fresenius Medical Care Institute for Advanced Clinical Trials for Children
Interactive Strategies
Jaspan Schlesinger LLP
JPA Health Communications
King & Spalding LLP
Latham & Watkins
Mallinckrodt Inc.
Mercury Public Affairs
Natera
National Renal Administrators Association
Northleaf Capital Partners
Omeros Corporation
OPKO Health - Renal Division
Orases PhRMA
PROTEK Consulting
RKD Group
Rockwell Medical Technologies Inc
Satter Investment Management
SPG Fiduciary Partners of Raymond James
Spherix Global Insights
SplitOak Strategies LLC
The Cooking Doc, LLC
The Meltzer Group NFP
Vendorin York Studios
Pharmaceutical Funding
- The total pharmaceutical revenue including donated product is $5,361,700
- The percentage of revenue from pharmaceutical companies is 1.59%
Note: Compliance with the U.S. Department of Health and Human Services Office of the Inspector General Opinion 97-1, under which the HIPP program operates, prohibits HIPP (Health Insurance Premium Program) donors to be included in this list.
Explore corporate partnership opportunities
Con el AKF, su ayuda llega más lejos
Esto fue lo que lograron en 2021 sus donaciones al AKF.
1,673 low-income dialysis patients
had kidney transplants and post-transplant care with AKF's financial support in 2025
75,000 dialysis and recent transplant patients
were able to afford health care coverage and other treatment-related expenses.
Over $2.7 million in grants
provided through our Safety Net Program to nearly 15,000 people living with kidney failure.
More than 50,000 AKF Ambassadors
from all 50 states and D.C. participated in our Advocacy Network, fighting for issues of importance to the kidney community.
More than 8,000 kidney health coaches
completed our training course to educate others about the importance of living a healthy lifestyle.
144 kids and teens
connected with their peers in Camp Connections for pediatric kidney patients.

